Look out, Pfizer: BridgeBio scores ‘best-case’ FDA nod for Attruby in cardiomyopathy
November 25, 2024A possible ban on DTC pharma ads poses ‘biggest threat’ of RFK Jr.’s HHS appointment: analyst
November 25, 2024Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH study
fkansteiner
Mon, 11/25/2024 – 08:50
